SEC Form 4 · accession 0000884731-16-000051
ARIAD PHARMACEUTICALS INC · ARIA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jules Haimovitz
Director
Period of report
May 4, 2016
Accepted (ET)
May 6, 2016 · 4:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884731
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $6.65 | May 4, 2016 | A | 75,000 | A | — | May 4, 2026 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1This stock option vests as to 25,000 shares on May 4, 2017,May 4, 2018 and May 4, 2019